Differential immunodetection of toxin B from highly virulent clostridium difficile BI/NAP-1/027

Journal of Clinical Microbiology

Volumn 53, Issue 5, 2015, Pages 1705-1708

  Pollock, Nira R ^a,b   Song, Linan ^c   Zhao, Mingwei ^c   Duffy, David C ^c   Chen, Xinhua ^a   Sambol, Susan P ^d   Gerding, Dale N ^d   Kelly, Ciarán P ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c QUANTERIX CORPORATION   (United States)

^d LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOSTRIDIUM DIFFICILE TOXIN B; MONOCLONAL ANTIBODY; BACTERIAL PROTEIN; BACTERIAL TOXIN; TOXB PROTEIN, CLOSTRIDIUM DIFFICILE;

ANTIGEN BINDING; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; CLOSTRIDIUM DIFFICILE BI NAP 1 027; FECES ANALYSIS; IMMUNOASSAY; IMMUNODETECTION; IN VIVO STUDY; INFECTION CONTROL; MOUSE; NONHUMAN; PEPTOCLOSTRIDIUM DIFFICILE; PRIORITY JOURNAL; PROGNOSIS; CHEMISTRY; CLOSTRIDIUM INFECTIONS; ENZYME LINKED IMMUNOSORBENT ASSAY; EVALUATION STUDY; FECES; HUMAN; IMMUNOLOGY; LABORATORY TEST; METABOLISM; MICROBIOLOGY; PROCEDURES;

CLOSTRIDIUM DIFFICILE;

BACTERIAL PROTEINS; BACTERIAL TOXINS; CLINICAL LABORATORY TECHNIQUES; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FECES; HUMANS;

EID: 84928042245     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.03419-14     Document Type: Article

References (14)

1. Cohen SH, Gerding DN, Johnson S, Kelly CP, Loo VG, McDonald LC, Pepin J, Wilcox MH. 2010. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol 31:431-455. http://dx .doi.org/10.1086/651706.
2. Burnham CA, Carroll KC. 2013. Diagnosis of Clostridium difficile infection: an ongoing conundrum for clinicians and for clinical laboratories. Clin Microbiol Rev 26:604-630. http://dx.doi.org/10.1128/CMR .00016-13.
3. Rupnik M. 2008. Heterogeneity of large clostridial toxins: importance of Clostridium difficile toxinotypes. FEMS Microbiol Rev 32:541-555. http://dx.doi.org/10.1111/j.1574-6976.2008.00110.x.
4. Tenover FC, Novak-Weekley S, Woods CW, Peterson LR, Davis T, Schreckenberger P, Fang FC, Dascal A, Gerding DN, Nomura JH, Goering RV, Akerlund T, Weissfeld AS, Baron EJ, Wong E, Marlowe EM, Whitmore J, Persing DH. 2010. Impact of strain type on detection of toxigenic Clostridium difficile: comparison of molecular diagnostic and enzyme immunoassay approaches. J Clin Microbiol 48:3719-3724. http://dx.doi.org/10.1128/JCM.00427-10.
5. Warny M, Pepin J, Fang A, Killgore G, Thompson A, Brazier J, Frost E, McDonald LC. 2005. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet 366:1079-1084. http://dx.doi.org/10.1016/S0140-6736(05)67420-X.
6. Loo VG, Poirier L, Miller MA, Oughton M, Libman MD, Michaud S, Bourgault AM, Nguyen T, Frenette C, Kelly M, Vibien A, Brassard P, Fenn S, Dewar K, Hudson TJ, Horn R, Rene P, Monczak Y, Dascal A. 2005. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med 353:2442-2449. http://dx.doi.org/10.1056/NEJMoa051639.
7. Petrella LA, Sambol SP, Cheknis A, Nagaro K, Kean Y, Sears PS, Babakhani F, Johnson S, Gerding DN. 2012. Decreased cure and increased recurrence rates for Clostridium difficile infection caused by the epidemic C. Difficile BI strain. Clin Infect Dis 55:351-357. http://dx.doi .org/10.1093/cid/cis430.
8. Lanis JM, Heinlen LD, James JA, Ballard JD. 2013. Clostridium difficile 027/BI/NAP1 encodes a hypertoxic and antigenically variable form of TcdB. PLoS Pathog 9:e1003523. http://dx.doi.org/10.1371/journal.ppat .1003523.
9. Goorhuis A, Bakker D, Corver J, Debast SB, Harmanus C, Notermans DW, Bergwerff AA, Dekker FW, Kuijper EJ. 2008. Emergence of Clostridium difficile infection due to a new hypervirulent strain, polymerase chain reaction ribotype 078. Clin Infect Dis 47:1162-1170. http://dx.doi .org/10.1086/592257.
10. Lim SK, Stuart RL, Mackin KE, Carter GP, Kotsanas D, Francis MJ, Easton M, Dimovski K, Elliott B, Riley TV, Hogg G, Paul E, Korman TM, Seemann T, Stinear TP, Lyras D, Jenkin GA. 2014. Emergence of a ribotype 244 strain of Clostridium difficile associated with severe disease and related to the epidemic ribotype 027 strain. Clin Infect Dis 58:1723-1730. http://dx.doi.org/10.1093/cid/ciu203.
11. Rissin DM, Kan CW, Campbell TG, Howes SC, Fournier DR, Song L, Piech T, Patel PP, Chang L, Rivnak AJ, Ferrell EP, Randall JD, Provuncher GK, Walt DR, Duffy DC. 2010. Single-molecule enzymelinked immunosorbent assay detects serum proteins at subfemtomolar concentrations. Nat Biotechnol 28:595-599. http://dx.doi.org/10.1038/nbt.1641.
12. Kan CW, Rivnak AJ, Campbell TG, Piech T, Rissin DM, Mosl M, Peterca A, Niederberger HP, Minnehan KA, Patel PP, Ferrell EP, Meyer RE, Chang L, Wilson DH, Fournier DR, Duffy DC. 2012. Isolation and detection of single molecules on paramagnetic beads using sequential fluid flows in microfabricated polymer array assemblies. Lab Chip 12:977-985. http://dx.doi.org/10.1039/C2LC20744C.
13. Letourneur O, Ottone S, Delauzun V, Bastide MC, Foussadier A. 2003. Molecular cloning, overexpression in Escherichia coli, and purification of 6 His-tagged C-terminal domain of Clostridium difficile toxins A and B. Protein Expr Purif 31:276-285. http://dx.doi.org/10.1016/S1046-5928 (03)00165-7.
14. Kyne L, Warny M, Qamar A, Kelly CP. 2000. Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A. N Engl J Med 342:390-397. http://dx.doi.org/10.1056/NEJM200002103420604.